Joel Isaacson & Co., LLC Abbott Laboratories Transaction History

Joel Isaacson & Co., LLC

$2.07 Billion
Q3 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 2,047 shares of ABT stock, worth $240,031. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,047

Previous 2,047 -0.0%

Holding current value

$240,031

Previous $212,000 9.91%

% of portfolio

0.01%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $19,138 - $21,363	-190 Reduced 8.49%	2,047 $212,000
Q1 2024 Apr 29, 2024	BUY	$109.52 - $120.96 $40,522 - $44,755	370 Added 19.82%	2,237 $254,000
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $168,384 - $206,116	1,867 New	1,867 $205,000
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $185,461 - $224,163	-1,817 Closed	0 $0
Q4 2021 Jan 19, 2022	SELL	$115.53 - $141.46 $25,647 - $31,404	-222 Reduced 10.89%	1,817 $256,000
Q3 2021 Oct 21, 2021	BUY	$116.66 - $129.06 $32,781 - $36,265	281 Added 15.98%	2,039 $241,000
Q1 2021 Apr 23, 2021	BUY	$108.84 - $128.23 $191,340 - $225,428	1,758 New	1,758 $211,000
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $193,674 - $283,204	-3,083 Closed	0 $0
Q3 2019 Oct 15, 2019	SELL	$81.84 - $88.74 $91,087 - $98,767	-1,113 Reduced 26.53%	3,083 $258,000
Q2 2019 Jul 11, 2019	BUY	$72.88 - $85.0 $76,669 - $89,420	1,052 Added 33.46%	4,196 $353,000
Q1 2019 Apr 09, 2019	SELL	$66.22 - $80.06 $20,395 - $24,658	-308 Reduced 8.92%	3,144 $251,000
Q4 2018 Jan 18, 2019	BUY	$65.56 - $74.27 $226,313 - $256,380	3,452 New	3,452 $239,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $205B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Account

Joel Isaacson & Co., LLC Abbott Laboratories Transaction History